Angiotensin-converting enzyme inhibitor induced angioedema of the head and neck.
Angiotensin-converting enzyme (ACE) inhibitors are now in widespread use for the treatment of essential and renovascular hypertension. Consequently, angioedema, an uncommon complication of ACE inhibitor therapy is being encountered with increasing frequency. Since ACE inhibitor angioedema predominantly involves the face, lips, oral cavity, and occasionally the larynx the otolaryngologist is often consulted to evaluate affected patients. Treatment ranges from simple cessation of the drug to emergent airway intervention. The pertinent pharmacologic properties of ACE inhibitors and the pathophysiology of angioedema are discussed. The authors' experience with the evaluation and treatment of ACE inhibitor induced angioedema is presented.
DiNardo
L J
LJ
Hospital of the University of Pennsylvania, Philadelphia 19104.
Hendrix
R A
RA
Anderson
G
G
DeDio
R M
RM
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000799:Angioedema / Q000139:chemically induced* / Q000188:drug therapy; D002216:Captopril / Q000009:adverse effects*; D004155:Diphenhydramine / Q000627:therapeutic use; D004656:Enalapril / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007818:Laryngeal Diseases / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced* / Q000188:drug therapy
D000305:Adrenal Cortex Hormones; D004656:Enalapril; D004155:Diphenhydramine; D002216:Captopril